Clinical trial
Low Dose Ketamine Infusion for Postoperative Analgesia After Total Knee Arthroplasty: Optimum Dose to Reduce Morphine Consumption
NCT04085588 is registered in ClinicalTrials.gov with Mustafa Kemal University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Low Dose Ketamine Infusion for Postoperative Analgesia After Total Knee Arthroplasty: Optimum Dose to Reduce Morphine Consumption
- Lead sponsor
- Mustafa Kemal University
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 15, 2019
- Completion date
- September 2, 2021
- Enrollment
- 75 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.